Skip to Content

What is the difference between Cyltezo and Humira?

Answers (1)

Official Answer by Drugs.com 10 Oct 2017

Cyltezo (adalimumab-adbm), from Boehringer Ingelheim, is a biosimilar to Humira (adalimumab). Both are anti-TNF-α monoclonal antibodies. A biosimilar, according to the FDA, is a biological product that is highly similar to an FDA-approved biological product, known as a reference product (in this case Humira), and has no clinically meaningful differences in terms of safety and effectiveness.

Both biologics are used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, adult Crohn’s disease, ulcerative colitis, and plaque psoriasis. Cyltezo is not an interchangeable product with Humira; the physician must write a prescription specifically for Cyltezo.

See also: https://www.drugs.com/compare/cyltezo-vs-humira

Drugs.com free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What type of cancer is Daurismo (glasdegib) used to treat?

Updated 5 days ago 1 answerFAQ by Drugs.com

What type of drug is Vitrakvi (larotrectinib)?

Updated 5 days ago 1 answerFAQ by Drugs.com

What is the difference between Truxima and Rituxan?

Updated 5 days ago 1 answerFAQ by Drugs.com

What type of leukemia is Xospata (gilteritinib) used to treat?

Updated 5 days ago 1 answerFAQ by Drugs.com

What is the difference between Tolsura and Sporanox?

Updated 4 days ago 1 answerFAQ by Drugs.com